Invention Grant
- Patent Title: Molecules for administration to ROS1 mutant cancer cells
-
Application No.: US14623904Application Date: 2015-02-17
-
Publication No.: US10231965B2Publication Date: 2019-03-19
- Inventor: Jonathan Lim , Elena Ardini , Maria Menichincheri
- Applicant: Ignyta, Inc. , Nerviano Medical Sciences S.r.l.
- Applicant Address: US CA San Diego IT Nerviano
- Assignee: IGNYTA, INC.,NERVIANO MEDICAL SCIENCES S.R.L.
- Current Assignee: IGNYTA, INC.,NERVIANO MEDICAL SCIENCES S.R.L.
- Current Assignee Address: US CA San Diego IT Nerviano
- Agency: Foley & Lardner LLP
- Main IPC: A61K31/496
- IPC: A61K31/496 ; C07D405/14

Abstract:
Substituted indazole derivatives of formula (I) or formula 2.(I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a deregulated protein kinase activity, like cancer.
Public/Granted literature
- US20150283132A1 MOLECULES FOR ADMINISTRATION TO ROS1 MUTANT CANCER CELLS Public/Granted day:2015-10-08
Information query
IPC分类: